Skip to content

Investigating the effectiveness of mindfulness on the food craving trait

Investigating and comparing the effectiveness of a mindfulness-based intervention along with standard treatment compared to standard treatment alone on the food craving trait in overweight and obese individuals with mild to moderate anxiety and/or depression: a randomized controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210507051204N2
Enrollment
60
Registered
2024-01-09
Start date
2024-05-21
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and obesity. Overweight and obesity

Interventions

Intervention 1: Control group: will receive standard treatment, which includes a normal caloric restriction diet tailored to the individual, which is determined by a nutritionist based on factors such

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: BMI>=25 Mild to moderate anxiety or depression: according to the DASS-21 questionnaire, a score of 7 to 12 in men and 9 to 14 in women for the depression subscale, or a score of 6 to 11 in men and 8 to 12 in women for the anxiety subscale Access to a smart phone and the ability to use it to receive and use the files related to study Having sufficient literacy (reading and writing) to complete forms and questionnaires Living in Isfahan city or nearby towns and villages Willingness to participate in the study

Exclusion criteria

Exclusion criteria: Being a candidate for bariatric surgery History of bariatric surgery in the last 18 months Age less than 18 or more than 65 years Having mental disabilities, blindness or deafness Being treated in other centers or participating in other similar studies Having a history of acute psychological diseases such as major depression, bulimia, anorexia, suicide or suicidal thoughts, schizophrenia, acute personality disorders, severe anxiety and depression, panic disorder and drug addiction. History of hospitalization due to psychological diseases History of diseases affecting appetite and weight gain/loss such as hypo/hyperthyroidism, liver cirrhosis, uncontrolled metabolic diseases, immune diseases and malignancy Taking drugs that have a significant effect on metabolism or appetite, such as corticosteroids, psychiatric drugs, and hormonal drugs Previous familiarity with and regular use of mindfulness-based techniques (more than or equal to three times a week, each time 10 minutes or more) Pregnant or lactating women Not willing to participate in the study or withdrawing from cooperation at any stage of the study

Design outcomes

Primary

MeasureTime frame
Food craving-trait score from FCQ-T-r questionnaire. Timepoint: The beginning of the study (before the start of the intervention), 2, 6, 10 and 14 weeks after starting to use the audio files. Method of measurement: FCQ-T-r questionnaire.

Secondary

MeasureTime frame
Binge eating. Timepoint: The beginning of the study (before the start of the intervention), 2, 6, 10 and 14 weeks after starting to use the audio files. Method of measurement: Binge eating scale questionnaire.;Anxiety level. Timepoint: The beginning of the study (before the start of the intervention), 2, 6, 10 and 14 weeks after starting to use the audio files. Method of measurement: Anxiety subscale of 21 question version of depression-anxiety-stress scale questionnaire.;Depression level. Timepoint: The beginning of the study (before the start of the intervention), 2, 6, 10 and 14 weeks after starting to use the audio files. Method of measurement: Depression subscale of 21 question version of depression-anxiety-stress scale questionnaire.;Mindful eating level. Timepoint: The beginning of the study (before the start of the intervention), 2, 6, 10 and 14 weeks after starting to use the audio files. Method of measurement: Mindful-Eating questionnaire.;Mindfulness level. Timepoint: The beginning of the study (before the start of the intervention), 2, 6, 10 and 14 weeks after starting to use the audio files. Method of measurement: Philadelphia mindfulness scale questionnaire.;Satisfaction level regarding the therapy. Timepoint: The beginning of the study (before the start of the intervention), 2, 6, 10 and 14 weeks after starting to use the audio files. Method of measurement: visual analogue scale.;Body mass index. Timepoint: The beginning of the study (before the start of the intervention), 2, 6, 10 and 14 weeks after starting to use the audio files. Method of measurement: weight in kilograms divided by height in meters squared.;Weight. Timepoint: The beginning of the study (before the start of the intervention), 2, 6, 10 and 14 weeks after starting to use the audio files. Method of measurement: body analyzer.;Body composition. Timepoint: The beginning of the study (before the start of the intervention), 2, 6, 10 and 14 weeks after starting to use the audio files. Meth

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Amirhossein Allameh

Esfahan University of Medical Sciences

sahallameh@gmail.com+98 31 3792 3179

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026